Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EMD Serono Appoints CMO

This article was originally published in Scrip

Executive Summary

EMD Serono, the US biopharmaceutical business of Merck KGaA., has appointed Joseph Leveque as chief medical officer (CMO). Leveque has over 20 years' experience in strategic leadership roles and medical and clinical programs and has been the medical lead in various biopharmaceutical roles. He joins EMD Serono from Bristol-Myers Squibb where he was head of US medical for oncology. Prior to this, he held medical affairs leadership positions at Onyx Pharmaceutical, Inc., Cephalon and Amgen, Inc.



Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst